palmitoylethanolamide.com.au
HomeResearchAbramo 2017

Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture model

Abramo F, Lazzarini G, Pirone A, Lenzi C, Albertini S, della Valle MF, Schievano C, Vannozzi I, Miragliotta V. Vet Dermatol. 2017;28(5):456-e104.

Laboratory studyDogs

Design
Laboratory study
Subjects
Skin biopsies from three healthy donor dogs, cultured in triplicate (ex vivo)
Dose used in the study
Ultramicronised PEA 30 micromolar in the culture medium, given 24 hours before and 72 hours with compound 48/80 (10 or 100 micrograms/mL), a mast cell secretagogue
Duration
5 days of culture
What was measured
Degranulating mast cells per square millimetre; histamine in the medium; capillary diameter; epidermal thickness, keratinocyte proliferation and differentiation markers

What the authors reported

Compound 48/80 caused mast cell degranulation and capillary dilation. PEA reduced degranulating mast cells (p < 0.005 and p < 0.01 at the two concentrations) to levels no different from untreated skin, and reversed the vasodilation at the higher concentration (p < 0.001). Histamine fell by about half but not significantly. PEA alone did not change the epidermis.

Limits of this study

Ex vivo skin from three dogs; the biopsy was the statistical unit. Single time point. Partly funded by Innovet, which makes the PEA product; one author is an Innovet consultant.

Source

PubMed 28581094 · doi:10.1111/vde.12456

Entry checked against the full text (open access), supplied by Devlin on 2026-09-21. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.